logo
Select company
Select metric
-6587.8%Free Cash Flow Margin
VS
Market
2
Sector
7
Industry
13
History
-
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -32.94M-6587.8%$ 500K
3/31/2025$ -33.19M0%$ 0
12/31/2024$ -32.83M0%$ 0
6/30/2024$ -20.03M-1837.45%$ 1.09M
12/31/2023$ -21.13M-211.32%$ 10M
6/30/2023$ -42.02M-471.56%$ 8.91M
12/31/2022$ -48.54M0%$ 0
6/30/2022$ -43.12M0%$ 0
12/31/2021$ -7.22M-15.83%$ 45.58M
6/30/2021$ -9.2M-20.17%$ 45.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) FCF % stands at 0%.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average FCF % has been -1524.02%.
  • The median FCF % for MEREO BIOPHARMA GROUP PLC during this period was -341.44%
  • MEREO BIOPHARMA GROUP PLC reached its highest FCF % over the past 5 years at -15.83%.
  • The lowest FCF % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -6587.8%

MEREO BIOPHARMA GROUP PLC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
CRDF : CARDIFF ONCOLOGY INC -7668.68%ABEO : ABEONA THERAPEUTICS INC -17822.75%HUMA : HUMACYTE INC -12994.01%AVTX : AVALO THERAPEUTICS INC -10752.38%COYA : COYA THERAPEUTICS INC -3890.1%ABVC : ABVC BIOPHARMA INC -448.8%FDMT : 4D MOLECULAR THERAPEUTICS INC -514584.85%VTGN : VISTAGEN THERAPEUTICS INC -7784.52%ERNA : ERNEXA THERAPEUTICS INC -2960.25%ANNX : ANNEXON INC -

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for MEREO BIOPHARMA GROUP PLC is calculated as follows: FCF [ $ -35.45M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]

MREO - Free Cash Flow Margin, Last 5 years

-6587.8%

Minimum

Jun 30, 2025

-15.83%

Maximum

Dec 31, 2021

-1524.02%

Average

-341.44%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.85%
median7.37%
std19.48%